1. Home
  2. VLY vs OGN Comparison

VLY vs OGN Comparison

Compare VLY & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLY
  • OGN
  • Stock Information
  • Founded
  • VLY 1927
  • OGN 1923
  • Country
  • VLY United States
  • OGN United States
  • Employees
  • VLY N/A
  • OGN N/A
  • Industry
  • VLY Major Banks
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLY Finance
  • OGN Health Care
  • Exchange
  • VLY Nasdaq
  • OGN Nasdaq
  • Market Cap
  • VLY 5.1B
  • OGN 4.7B
  • IPO Year
  • VLY N/A
  • OGN N/A
  • Fundamental
  • Price
  • VLY $10.38
  • OGN $14.99
  • Analyst Decision
  • VLY Hold
  • OGN Hold
  • Analyst Count
  • VLY 10
  • OGN 3
  • Target Price
  • VLY $9.50
  • OGN $21.33
  • AVG Volume (30 Days)
  • VLY 9.2M
  • OGN 3.2M
  • Earning Date
  • VLY 10-24-2024
  • OGN 10-31-2024
  • Dividend Yield
  • VLY 4.28%
  • OGN 7.51%
  • EPS Growth
  • VLY N/A
  • OGN 120.97
  • EPS
  • VLY 0.62
  • OGN 5.04
  • Revenue
  • VLY $1,577,035,000.00
  • OGN $6,409,000,000.00
  • Revenue This Year
  • VLY N/A
  • OGN $3.13
  • Revenue Next Year
  • VLY $6.66
  • OGN $2.18
  • P/E Ratio
  • VLY $16.45
  • OGN $2.95
  • Revenue Growth
  • VLY N/A
  • OGN 4.21
  • 52 Week Low
  • VLY $6.47
  • OGN $10.84
  • 52 Week High
  • VLY $11.22
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • VLY 63.91
  • OGN 31.10
  • Support Level
  • VLY $9.98
  • OGN $14.39
  • Resistance Level
  • VLY $10.39
  • OGN $15.85
  • Average True Range (ATR)
  • VLY 0.28
  • OGN 0.48
  • MACD
  • VLY -0.00
  • OGN -0.05
  • Stochastic Oscillator
  • VLY 80.65
  • OGN 24.54

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: